Related Experiment Video
Updated: Dec 28, 2025
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
PNA Clamping in Nucleic Acid Amplification Protocols to Detect Single Nucleotide Mutations Related to Cancer
Munira F Fouz1, Daniel H Appella1
1Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
Abstract:
This review describes the application of peptide nucleic acids (PNAs) as clamps that prevent nucleic acid amplification of wild-type DNA so that DNA with mutations may be observed. These methods are useful to detect single-nucleotide polymorphisms (SNPs) in cases where there is a small amount of mutated DNA relative to the amount of normal (unmutated/wild-type) DNA. Detecting SNPs arising from mutated DNA can be useful to diagnose various genetic diseases, and is especially important in cancer diagnostics for early detection, proper diagnosis, and monitoring of disease progression. Most examples use PNA clamps to inhibit PCR amplification of wild-type DNA to identify the presence of mutated DNA associated with various types of cancer.
Insights
Peptide nucleic acids (PNAs) act as clamps to block normal DNA amplification, enabling the detection of mutated DNA. This is crucial for diagnosing genetic diseases and cancer through single-nucleotide polymorphism (SNP) analysis.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Wild-type DNA amplification can obscure the detection of rare mutated DNA sequences.
- Single-nucleotide polymorphisms (SNPs) are key indicators of genetic diseases and cancer.
- Accurate detection of mutated DNA is vital for early diagnosis and disease management.
Purpose of the Study:
- To review the application of peptide nucleic acids (PNAs) as clamps for detecting mutated DNA.
- To highlight the utility of PNA clamps in identifying single-nucleotide polymorphisms (SNPs) in low-prevalence mutation scenarios.
- To emphasize the importance of PNA-based methods in cancer diagnostics.
Main Methods:
- Utilizing peptide nucleic acids (PNAs) as clamps to specifically inhibit the amplification of wild-type DNA.
- Employing techniques that leverage PNA clamp inhibition to reveal the presence of mutated DNA.
- Focusing on Polymerase Chain Reaction (PCR) based amplification inhibition by PNA clamps.
Main Results:
- PNA clamps effectively prevent the amplification of wild-type DNA sequences.
- This selective inhibition allows for the clear observation and detection of mutated DNA, even at low concentrations.
- The method demonstrates high utility in identifying cancer-associated SNPs.
Conclusions:
- Peptide nucleic acid (PNA) clamps are a powerful tool for enhancing the detection of mutated DNA.
- These methods are particularly valuable for SNP detection in genetic disease and cancer diagnostics.
- PNA clamp technology offers significant potential for early disease detection and personalized medicine.
More Related Videos
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
08:23Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018